Infliximab (chimeric anti-tumor necrosis factor α (monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. - Maini,R.; St,C.lair EW.; Breedveld,F. (Lancet, 1999)